Evidence map›Paper›PMID 35434600›Full record

ArticleFood chemistry: X2022

Kombucha - An ancient fermented beverage with desired bioactivities: A narrowed review.

Nurten Abaci, Fatma Sezer Senol Deniz, Ilkay Erdogan Orhan

Abstract read
In one paragraph

Article in Food chemistry: X, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Antiobesity potential of major metabolites fromCurrent research in food science · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nurten AbaciDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey.
Fatma Sezer Senol DenizDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey.
Ilkay Erdogan OrhanDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kombucha, originated in China 2000  years ago, is a sour and sweet-tasted drink, prepared traditionally through fermentation of black tea. During the fermentation of kombucha, consisting of mainly acidic compounds, microorganisms, and a tiny amount of alcohol, a biofilm called SCOBY forms. The bacteria in kombucha has been generally identified as Acetobacteraceae. Kombucha is a noteworthy source of B complex vitamins, polyphenols, and organic acids (mainly acetic acid). Nowadays, kombucha is tended to be prepared with some other plant species, which, therefore, lead to variations in its composition. Pre-clinical studies conducted on kombucha revealed that it has desired bioactivities such as antimicrobial, antioxidant, hepatoprotective, anti-hypercholestorelomic, anticancer, anti-inflammatory, etc. Only a few clinical studies have been also reported. In the current review, we aimed to overhaul pre-clinical bioactivities reported on kombucha as well as its brief compositional chemistry. The literature data indicate that kombucha has valuable biological effects on human health.

Indexed as

ABTS, 2,2-azinobis-(3-ethylbenzotiazoline-6-sulfonic acid)ACE, Angiotensin-converting enzymeAHA, Alpha hydroxy acidALP, Alkaline phosphataseALT, Alanine aminotransferaseAMPK, Adenosine monophosphate-activated protein kinaseAST, Aspartate aminotransferaseATCC, American type culture collectionBBB, Blood-brain barrierBioactivityBiofilmCAT, CatalaseCOVID-19, Coronavirus disease of 2019DNA, Deoxyribonucleic AcidDPPH, 2,2-diphenyl-1-picrylhydrazylDSL, d-Saccharic acid-1,4-lactoneEGCG, Epigallocatechin gallateFermented drinkFRAP, Ferric reducing antioxidant powerGC–MS, Gas chromatography- mass spectrometryGGT, Gamma glutamyl transferaseGPx, Glutathione peroxidaseGRx, Glutathione reductaseGST, Glutathione S-transferaseHbA1c, Glycosylated Hemoglobin, Type A1CHDL, High density lipoproteinHPLC/ESI–MS, High-performance liquid chromatography/electrospray ionization-mass spectrometryHPLC, High-performance liquid chromatographyHPLC-MS/MS, High-performance liquid chromatography- mass spectrometry/ mass spectrometryHPLC-UV-ESI-MS, High-performance liquid chromatography-ultraviolet- electrospray ionization-mass spectrometryIC50, Half maximal ınhibitory concentrationIL, InterleukinKombuchaLC-MS, Liquid chromatography–mass spectrometryLDH, Lactate dehydrogenaseLDL, Low-density lipoproteinLOX, LipoxygenaseLPS, LipopolysaccharideMCD, Methionine/choline-deficient dietMCDM, Multi-criteria decision-making MDA, MalondialdehydeMIC, Minimum inhibitory concentrationMicroorganismNAD, Nicotinamide adenine dinucleotideNAFLD, Non-alcoholic fatty liver diseaseNO, Nitric oxideORAC, Oxygen radical absorbance capacityRNS, Reactive nitrogen speciesROS, Reactive oxygen speciesSASP, Senescence-associated secretory phenotypeSCOBY, Symbiotic culture of bacteria and yeastSMC, Synthetic microbial communitySOD, Superoxide dismutaseSPF, Sun Protection FactorTAA, ThioacetamideTEAC, Trolox-equivalent antioxidant capacityTE, Trolox equivalentTG, TriglycerideTLC, Thin-layer chromatographyTNF-α, Tumour necrosis factor alphaUVB, Ultraviolet radiation-BVLDL, Very low-density lipoproteinWGJ, Wheatgrass juiceWoS, Web of Science

Identifiers

PMID35434600
PMCPMC9011011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.